5WN-27239-15466
5 vaccinations
2 coded responses
50 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 223 / VA
- Registered
- 2021-04-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-14
Registered in v-safe
-
2021-04-14
Dose 1 — Moderna
- 2021-04-14
-
2021-04-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-21
-
2021-04-28
Survey response — day 14, dose 1MedDRA: Injection site rash — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Rash at injection site starting at day 8 and lasting 2-3 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-05
-
2021-05-14
Dose 2 — Moderna
-
2021-05-14
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · HeadacheAdult check-in
-
2021-05-15
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-16
- 2021-05-18
- 2021-05-19
- 2021-05-20
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-06-18
- 2021-06-25
- 2021-08-13
- 2021-11-14
-
2021-11-17
Dose 3 — Moderna
-
2021-11-18
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2021-12-17
- 2021-12-24
- 2021-12-29
- 2022-02-16
- 2022-04-09
-
2022-04-13
Dose 4 — Moderna
-
2022-09-21
Dose 5 — Moderna
- 2022-09-21
-
2022-09-22
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain, Redness · Muscle or body achesAdult check-in
-
2022-09-23
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body achesAdult check-in
-
2022-09-24
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-12-21
- 2023-03-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-14 | Moderna | |
| 2 | 2021-05-14 | Moderna | |
| 3 | 2021-11-17 | Moderna | No |
| 4 | 2022-04-13 | Moderna | No |
| 5 | 2022-09-21 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-28 | Unsuccessful |
Free text
Release 8 — day 14, dose 1
Symptoms: Rash at injection site starting at day 8 and lasting 2-3 days
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release